Australian (ASX) Stock Market Forum

IMM - Immutep Limited

Jump to new
Someone said PRR could go north of $3 on the ASX IF FDA approved in 2/3 years. How?

In an amazing world and unbelievable rise I can only see it get $1.40 on the ASX. (When bundled as 30)

Unless you have 3,000,000 shares wont be retiring here.

I know $1.40 would be fantastic its just it will hurt seeing it sit at $42 on the NASDAQ while its sits at 1.40 on the ASX.
 
An interesting graphic on the front page of BioCentury.com. Shows where all the capital for biotech research is coming from. GO ASX! LOL

http://www.biocentury.com/home


Capture.PNG
 
Last chance to dance tomorrow for the SPP. Glad to see the back of it quite honestly. Looking at the depth I think I'll chance my arm and top up with the SPP a bit on the visa for my trading account and hope like hell we list on the Nasdaq very soon and gap up considerably.

Failing that I have two kidneys and probably can get by with one :behead:
 
Good to see you posting Slippers. I don't want to contradict you on the kidney reduction project but you were the poster who allerted me to ALK ages ago. Didn't you make a fortune on ALK? Silly me I sold after v. small profit compared to what was coming. I hope you were smarter.
My hopes in PRR now, the company seems to be having huge potential and Prima's world class team of very creative experts add the X factor to the project. GO PRR: :D
 
Wysiwyg said:
I remember Les (with the beard) saying all good for Prima (PRR) when they were around 6 or 7 cents. They duly reached an intraday of high of 28 cents. LOL. Hasn't Julia Lee got the sweetest smile. :)
Click to expand...
I posted this on the 26th June 2010 in another thread. Recently purchased some crumbs at 28.5 cents for the first time since more certainty has developed with this company. Otherwise I rate bios/meds not too dissimilar to oilers in respect to potentially very high gains or losses. .
 
shanti said:
Good to see you posting Slippers. I don't want to contradict you on the kidney reduction project but you were the poster who allerted me to ALK ages ago. Didn't you make a fortune on ALK? Silly me I sold after v. small profit compared to what was coming. I hope you were smarter.
My hopes in PRR now, the company seems to be having huge potential and Prima's world class team of very creative experts add the X factor to the project. GO PRR: :D
Click to expand...

Thanks shanti. Yes I did make a few dollars on ALK but was in and out pretty quickly so like you I missed a bit of profit but did ok! The value of hindsight :rolleyes:

Anyhoo found this today. Seems the Euros are on the case as well and getting some good results hopefully helping to smooth a pathway to approval in the EU for CVac in the near future :) Translation is a bit ordinary but a good read

http://kanker-actueel.nl/EN/dendritic-cell-therapy-vaccination-against-cancer-nijmegen-research-stimulates-immune-system-in-cultured-cells.html
 
Slipperz said:
An interesting graphic on the front page of BioCentury.com. Shows where all the capital for biotech research is coming from. GO ASX! LOL

http://www.biocentury.com/home


View attachment 43231
Click to expand...

And what would most astute American investors read...the Wall Street Journal perhaps? http://online.wsj.com/article/SB10001424052702303936704576397582460729752.html

Great to see PRR ( PBMD) hitting the desks in the US of A at just the right time almost immediately prior to our Nasdaq listing. :)
 
Slipperz said:
And what would most astute American investors read...the Wall Street Journal perhaps? http://online.wsj.com/article/SB10001424052702303936704576397582460729752.html

Great to see PRR ( PBMD) hitting the desks in the US of A at just the right time almost immediately prior to our Nasdaq listing. :)
Click to expand...

Well if cash burn was our last hurdle to the Nasdaq we're in the last 20 metres to the tape now.

SPP oversubscribed in both tranches. Lift off in SP next week after allocation will be interesting to watch :cool:
 
I've been watching PRR, and I've read a lot of talk about this Nasdaq listing, and I'm wondering what affect it's going to have on it's ASX listing?

Also, broadly speaking (but specifically with PRR), why do Australian companies get listed on other exchanges?
 
Starcraftmazter said:
I've been watching PRR, and I've read a lot of talk about this Nasdaq listing, and I'm wondering what affect it's going to have on it's ASX listing?

Also, broadly speaking (but specifically with PRR), why do Australian companies get listed on other exchanges?
Click to expand...

Exposure - more people willing to trade = larger volume = (hopefully) positive sp movements.
 
Slipperz said:
SPP oversubscribed in both tranches. Lift off in SP next week after allocation will be interesting to watch :cool:
Click to expand...
There is a gathering around 30 cents that don't want to profit any higher than that price. There is resistance and persistence with one eventual winner and let's hope it isn't the stone wall brigade.
 
Wysiwyg said:
There is a gathering around 30 cents that don't want to profit any higher than that price. There is resistance and persistence with one eventual winner and let's hope it isn't the stone wall brigade.
Click to expand...

Wall smashed and we're on the move again! Great to see us untethering from the SPP. And for all who did participate in the SPP heres a link to a forum that gives you a pretty good idea on how the money is going to be spent. Makes me feel pretty good. :)

https://www.inspire.com/groups/ovarian-cancer-national-alliance/discussion/is-anyone-on-cvac-trial-dendritic-cell-vaccine/
 
Just found another company in the US that is looking like a direct competitor in the market. http://www.nwbio.com/

Even sounds like Cvac! But the positive is their lead products are targeting brain and prostrate cancer and FDA approval is only going to add credence to the technology.Looking at their timelines though and they are also targeting a number of other cancers including ovarian. From their home page...

" The Company’s lead product candidate is DCVax ®-Brain which targets Glioblastoma Multiforme (‘‘GBM’’), the most lethal form of brain cancer. DCVax ®-Brain has entered a Phase II FDA-allowed clinical trial, which is designed and powered as a pivotal trial (i.e. a trial from which a company may go directly to product approval). "

So how do they go from Phase II to approval exactly? Is this just spin or is the FDA openly accepting that dendritic cell therapy works and is opening the market to the various forms of therapy for each cancer? :eek:

And while I'm on a rhetorical question tip why do they only have a market cap of 58 million? Could this be a nice find on the overseas markets perhaps??? :cautious:
 
Slipperz said:
So how do they go from Phase II to approval exactly? Is this just spin or is the FDA openly accepting that dendritic cell therapy works and is opening the market to the various forms of therapy for each cancer? :eek:

And while I'm on a rhetorical question tip why do they only have a market cap of 58 million? Could this be a nice find on the overseas markets perhaps??? :cautious:
Click to expand...

Have you found the answer Slipperz? I'm having the same thought too.
 
Slipperz said:
Wall smashed and we're on the move again! Great to see us untethering from the SPP. And for all who did participate in the SPP heres a link to a forum that gives you a pretty good idea on how the money is going to be spent. Makes me feel pretty good. :)
Click to expand...
Bit of a false break of resistance. Sometimes these pullbacks are privileged information driven but if so we won't know until it comes out.
 
grandia3 said:
it reaches a low of 0.26 today
will we get back to 0.225ish? :confused:
Click to expand...
IMHO it depends on today's Close:
If it holds 27.5c, it's most likely rising off a bottom reversal hammer.
If 26c were revisited, the signs would look rather Bearish.
I hold and shall wait how tomorrow's candle will shape up.

PRR n 18-07-11.gif
 
Top